Our Regulation A Offering closed strongly this weekend, with Quadrant successfully raising in approximately one million dollars to help fund our continuing mission to develop and commercialize epigenetic diagnostic tests for neurological health conditions, such as our Clarifi ASD autism saliva test! 

Thank you to everyone who participated in our Regulation A Offering! We very much appreciate your belief in our mission and we are honored to have you join us on our journey forward! With your help we will continue our development of epigenetic diagnostic tests, and also continue to work with our university partners in wastewater surveillance for Covid-19. 

We hope you will continue to follow our progress at www.quadrantbiosciences.com. We also plan to periodically send email updates to all our investors about the latest Quadrant Biosciences news. You can also stay up to date with us by following us Facebook, Twitter, Instagram, and LinkedIn as well. Together, we can make a difference.

Thank you again for your support!